← Back to Search

ACL Reconstruction With/Without Internal Bracing for Anterior Cruciate Ligament Injury

N/A
Waitlist Available
Led By David Trofa, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 10 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether adding an internal brace during ACL surgery helps patients recover faster and have better outcomes. It focuses on young adults and athletes who need strong and stable knees. The brace is supposed to make the new ligament stronger and more stable while it heals. Internal bracing of the anterior cruciate ligament (ACL) reinforces the ligament and encourages natural healing by protecting it during the healing phase and supporting early mobilization.

Who is the study for?
This trial is for patients treated by Columbia University Sports Medicine Service, aged 12 or older, with a first-time ACL injury confirmed by clinical exam and MRI. It's not suitable for those with previous knee surgery, other knee injuries, neuromuscular disorders affecting the leg, anesthesia risks, or who can't/won't follow the study plan.
What is being tested?
The study compares two ways to fix an ACL tear: both use a patient's own bone-tendon-bone graft but one adds internal brace augmentation (suture tape). The goal is to see if this extra support helps people get back to activities faster and improves their experience post-surgery.
What are the potential side effects?
Potential side effects may include pain at the graft site, swelling in the knee joint, stiffness or loss of motion in the knee. There might also be complications from surgery such as infection or issues related to anesthesia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 10 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in PROMIS Depression CAT at 1 year
Change in PROMIS Depression CAT at 10 years
Change in PROMIS Depression CAT at 2 weeks
+23 more
Secondary study objectives
Change in International Knee Documentation Committee (IKDC) Score at 1 year
Change in International Knee Documentation Committee (IKDC) Score at 10 years
Change in International Knee Documentation Committee (IKDC) Score at 2 weeks
+45 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ACL reconstruction with internal brace augmentation (suture tape)Experimental Treatment2 Interventions
This group will receive a standard ACL reconstruction using a BTB autograft with suture tape augmentation on the graft to strengthen it during the surgical procedure.
Group II: ACL reconstruction without internal brace augmentationActive Control2 Interventions
This group will only receive a standard ACL reconstruction using a BTB autograft. No suture tape will be added to the graft during the surgical procedure.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Anterior Cruciate Ligament (ACL) tears include surgical reconstruction using autografts (patient's own tissue) or allografts (donor tissue), and internal brace augmentation. Surgical reconstruction involves replacing the torn ligament with a graft, which provides a scaffold for new tissue growth and restores knee stability. Internal brace augmentation, a newer technique, involves the use of a synthetic brace to reinforce the graft, increasing its load failure capacity and stabilizing it in-situ. This is particularly important for ACL tear patients as it may enhance the initial stability of the reconstruction, potentially leading to a quicker and more reliable return to activity.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,492 Previous Clinical Trials
2,664,658 Total Patients Enrolled
David Trofa, MDPrincipal InvestigatorAssistant Professor of Orthopedic Surgery
2 Previous Clinical Trials
400 Total Patients Enrolled

Media Library

ACL reconstruction with BTB autograft with internal brace augmentation (suture tape) Clinical Trial Eligibility Overview. Trial Name: NCT05532189 — N/A
Anterior Cruciate Ligament Tear Research Study Groups: ACL reconstruction with internal brace augmentation (suture tape), ACL reconstruction without internal brace augmentation
Anterior Cruciate Ligament Tear Clinical Trial 2023: ACL reconstruction with BTB autograft with internal brace augmentation (suture tape) Highlights & Side Effects. Trial Name: NCT05532189 — N/A
ACL reconstruction with BTB autograft with internal brace augmentation (suture tape) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05532189 — N/A
~133 spots leftby Sep 2032